QA: Celldex Therapeutics Inc. in us_medicinal_products/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000744218_2018_Celldex_Therapeutics_Inc.pdf

Logs

info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'}

Graph

Absolute values for 0000744218, Celldex Therapeutics Inc.

  xvar xval
0 LiabilitiesNoncurrent 51,519,000
1 LiabilitiesCurrent 27,736,000
2 remainder_Liabilities 0
3 AssetsCurrent 144,756,000
4 AssetsNoncurrent 1,929,000
5 PropertyPlantAndEquipmentNet 10,372,000
6 Goodwill 158,567,000
7 remainder_Assets 0
8 GeneralAndAdministrativeExpense 25,003,000
9 ResearchAndDevelopmentExpense 96,171,000
10 remainder_Expenses -11,186,000
11 remainder_Revenues 16,957,000
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 23,000
  yvar yval
0 Liabilities 79,255,000
1 Assets 315,624,000
2 Expenses 109,988,000
3 Revenues 16,957,000
4 StockholdersEquity 236,369,000
5 NetIncome -93,031,000
6 ComprehensiveNetIncome -93,019,500
7 BaseVar 260,923,500
8 EconomicCapitalRatio 0.546

Edgar->Model Mapping

Feature Distribution

Change over Time